- Epistrophy Capital Research
- Posts
- Epistrophy Week Ahead
Epistrophy Week Ahead
The Week Of March 9, 2026

As the war wages on in the middle east, we turn our focus to the meltdown in private credit and, in particular, one private credit firm in Silicon Valley that seems to have been left out of the discussion.
We’ll also be paying attention to the earnings from Hewlett Packard Enterprise (HPE: NYSE) and getting ready for the big events of the following week, NVIDIA GTC in San Jose and perhaps just as momentous, the annual Optical Fiber Communications conference being held in downtown Los Angeles for the first time (reach out if you’d like to attend our cocktail party on Tuesday, March 17.)
Companies Discussed
Ticker | Name | Market Cap ($B) | Price |
TPVG | Triplepoint Venture Growth BDC | $0.21 B | $5.27 |

Troubled startups backed by TriplePoint include plus-sized clothing retailer Dia & Co., Dutch e-bike maker VanMoof and subscription tackle-box retailer Catch Co.
TriplePoint’s PIK Problem
When Private Credit Meets Silicon Valley
The private credit boom has been built on a simple promise: steady income from loans too complex or illiquid for public markets. That promise is starting to fray. On March 6, BlackRock said it would limit withdrawals from its $26 billion HPS Corporate Lending Fund, capping redemptions at 5% after investors sought to pull roughly 9.3% of the fund. The decision marked the clearest example yet of gating in one of the industry’s flagship retail credit vehicles and underscored growing tension in a $1.8 trillion asset class that has expanded faster than its liquidity.
Silicon Valley's version of private credit is called “venture debt.” Given the news flow, it’s worth taking another look at TriplePoint Venture Growth BDC Corp (TPVG: NYSE).

TriplePoint lends money to sometimes-desperate startups at above-market rates. In the just-reported fourth quarter its average yield was 12.7%. (TriplePoint’s yields have been falling, and were as high as 15.8% just six quarters ago.)
When the companies run into trouble and cannot make their payments TriplePoint converts those non-payments into “payment-in-kind” interest PIK which allows borrowers to add interest to the principal balance rather than pay cash. TriplePoint records income today. The borrower promises to pay later.
At TriplePoint Venture Growth BDC Corp (TPVG: NYSE), the public company is little more than a pool of capital; the real economic beneficiary is its external adviser, TriplePoint Advisers LLC. That advise , controlled by CEO Jim Labe and CIO Sajal Srivastava, collected $13.5 million in base management fees in 2025 – equal to about 6.3% of the firm’s market capitalization. The fee is calculated as 1.75% of gross assets, meaning it grows when the loan book expands even if the company’s stock collapses or loans deteriorate. Accepting PIK interest also expands the size of the portfolio even as asset quality deteriorates.

In a year when the firm generated $42.3 million in net investment income, management paid itself 32% of the portfolio’s cash earnings before shareholders received a penny. The structure goes further: the adviser is also entitled to 20% of investment income above a hurdle, meaning rising reported income — including non-cash payment-in-kind interest — can boost the adviser’s compensation. Because Labe and Srivastava have indirect economic interests in the adviser receiving those payments, the arrangement funnels a steady stream of fees to management even as shareholders absorb the credit risk of the underlying loans.
Non-cash PIK payments grow the portfolio’s debt even as the advisor extracts cash. It has now reached a point where PIK income accounts for most of the portfolio’s growth.

TriplePoint’s portfolio of venture-backed technology loans shows how the private credit machine can continue generating reported income even as cash flows weaken. Over the past two years, the company’s filings show cash interest from investments declining while PIK interest has climbed sharply.
What kind of startups borrow from TriplePoint? Many are promising and perform well, but these are not the OpenAIs and SpaceXs of the world. TriplePoint says 82.1% of the companies they’ve lent to in 2025 are “Clear” or “White” – meaning they require only periodic review every quarter. The company won’t say which of those companies are so trustworthy.
But their recent estimations of some credit risk are disconcerting, including:
Company | Location | Pitch | Distress Event |
|---|---|---|---|
RenoRun | Montreal | Construction materials delivery platform | November 2023 |
The Pill Club (Favor) | San Mateo | Birth-control telehealth subscription service | April 2023 |
VanMoof | Amsterdam | e-bike maker | July 2023 |
Luko | Paris | Digital renters- insurance startup | January 2023 |
Catch Co. | Chicago | Fishing-gear subscription boxes | March 2024 |
Hi.Q | Palo Alto | AI-based customer- service analytics software | May 2022 |
JOKR | Berlin / New York | Short-lived “Groceries in minutes” quick-commerce delivery | June 2022 |
Dia & Co | New York | Plus-size (sizes 10-32) women’s subscription apparel retailer | March 2023 |
Frubana | Bogotá | Restaurant supply marketplace for food distributors | September 2023 |
Mynd Management | Oakland | Property-management platform for landlords | October 2023 |
Homeward | Austin | iBuyer platform helping buyers purchase homes | December 2022 |
Medly Health | New York | Digital pharmacy and prescription delivery | December 2022 |
The issue is not only liquidity. It is the nature of the income being generated inside many private credit portfolios. The loans that populate these funds are illiquid, opaque, and increasingly extended to borrowers whose ability to pay interest in cash is deteriorating. In other words, while BlackRock’s withdrawal gate highlights the liquidity tension in private credit funds, TriplePoint illustrates the credit tension beneath it.
For TriplePoint, increasingly, the income exists on paper. The cash increasingly does not.
Tweet O’ The Week

📆 of Epistrophy Events
Ticker | Name | Market Cap | Expected Date | Type |
|---|---|---|---|---|
HPE | Hewlett Packard Enterprise | $28 B | Mar 9 | Earnings |
Game Developers Confereece GDC | Mar 9 | Conference | ||
CPI | Consumer Price Index | Mar 11 | Economic Event | |
SNPS | Synopsys Users Group (SNUG) 2025 | $84 B | Mar 11 | Conference |
SNPS | SNUG Silicon Valley | $84 B | Mar 11 | Conference |
ADBE | Adobe | $116 B | Mar 12 | Earnings |
RBRK | Rubrik | $11 B | Mar 12 | Earnings |
PPI | Producer Price Index | Mar 12 | Economic Event | |
RS | Advance Retail & Food Services Sales | Mar 16 | Economic Event | |
IP | Industrial Production & Capacity Utilization | Mar 16 | Economic Event | |
NVDA | NVIDIA GTC AI Conference | $4,323 B | Mar 16 | Conference |
OFC 🔦 | Optical Fiber Communications Conf. | Mar 16 | Conference | |
NVDA | GTC 2026 | $4,323 B | Mar 16 | Conference |
NHC | New Residential Construction | Mar 17 | Economic Event | |
FOMC | FOMC two-day meeting | Mar 17 | Economic Event | |
FOMC | FOMC two-day meeting | Mar 17 | Economic Event | |
NRS | New Residential Sales | Mar 24 | Economic Event | |
DG_ADV | Durable Goods Orders (Advance) | Mar 25 | Economic Event | |
RSA Conference 2026 | Mar 26 | Conference | ||
GDP | GDP Third Q4 2025 | Mar 27 | Economic Event | |
PCE | Personal Income & Outlays (incl. PCE) | Mar 27 | Economic Event |
Availability This Week
I’ll be in our San Francisco office at the Ferry Building all week, then the travels begin — the Los Angeles Optical Fiber Communications conference will be a banger (I swear!) The stocks in this sector have been on fire in the last two years and we’ll be digging deep.
Written reports are available to clients, with video summaries on YouTube, and of course our popular summaries of the summaries on Instagram, TikTok, and YouTube Shorts.

We certify that (1) the views expressed in this report accurately reflect our views about all of the subject companies and securities and (2) no part of my compensation was, is or will be directly related to the specific recommendations or views expressed in this report.
Important disclosures
Important disclosures are available by calling (347) 619-2489 or writing to Epistrophy Capital Research, One Ferry Building, Suite 201, San Francisco, CA 94105.
Epistrophy Capital Research is an independent research provider and does not operate as a financial institution. Epistrophy explicitly does not provide investment advice, stock recommendations, or solicitations to buy or sell any securities.
The research reports provided by Epistrophy Capital Research contain opinions derived from publicly available information, issuer communications, recognized statistical services, and other reputable sources considered reliable. However, Epistrophy does not independently verify the accuracy or completeness of such information and explicitly disclaims responsibility for any errors or omissions.
Opinions and analysis contained within Epistrophy's research reports are current only at the time of publication and are subject to change without notice. Readers must independently verify facts and conduct their own due diligence before making investment decisions.
Epistrophy Capital Research does not consider or evaluate individual investor circumstances, including investment objectives, financial situations, or risk tolerance. Investing in securities, particularly small-cap and micro-cap stocks, involves substantial risks, including significant volatility and potential loss of principal. Readers are strongly advised to consult their financial advisor or another qualified professional before acting on any information provided. Readers should assume Epistrophy Capital Research, its principals or its contributors may have positions, long or short, any of the companies discussed and the Epistrophy Capital Research principals or contributors may have had or currently have business interests in the companies discussed.
Past performance referenced in Epistrophy reports is not indicative of future results. Security prices can fluctuate widely, and investors should be aware that investments can result in significant financial losses. Epistrophy Capital Research or its Unless explicitly stated otherwise, prices quoted in reports reflect market closing prices from the previous trading day.
Epistrophy Capital Research publications are intended solely for direct recipients and should not be redistributed or shared with third parties without explicit permission from Epistrophy Capital Research LLC.
Epistrophy Capital Research reports are provided strictly for informational purposes and do not constitute a comprehensive analysis of any company, security, or industry. No content within these reports should be considered accounting, tax, legal, or professional advice.
Links or references to third-party websites or external resources are provided solely for informational convenience. Epistrophy Capital Research expressly disclaims endorsement of, and responsibility for, the content, accuracy, or reliability of such external information. Accessing third-party information is done entirely at the user's own risk.
For additional details, clarification, or specific inquiries regarding Epistrophy Capital Research reports, please contact Epistrophy Capital Research LLC directly.
Reply